EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)
EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) is a high-performance, dual-reporting mRNA product designed for advanced gene expression and intracellular tracking studies. It combines robust protein expression with sensitive fluorescence detection in a single construct. This ready-to-use mRNA is ideal for real-time tracking of mRNA delivery, optimizing transfection protocols, and dual-modality studies combining bioluminescence imaging with fluorescence-based localization. It serves as a valuable tool in mRNA vaccine development, gene therapy research, and intracellular trafficking assays.
Key features:
Fluorescent Labeling: The mRNA is covalently conjugated with Cy5 dye, enabling direct visualization of mRNA delivery, cellular uptake, and intracellular trafficking using fluorescence microscopy or flow cytometry, without the need for secondary detection steps.
Cap1 Structure: The mRNA incorporates a Cap1 analog at the 5' end, ensuring high translation initiation efficiency, improved stability, and reduced innate immune recognition, leading to stronger and more sustained luciferase expression.
Modified Nucleotides: It contains 5-methoxyuridine (5-moU) modified nucleotides, which decreases immunogenicity, enhances mRNA stability, and increases translational efficiency, resulting in more reliable and reproducible protein yield.
| mRNA Length | 1921 nucleotides |
| Concentration | 1 mg/mL |
| Buffer | 1 mM Sodium Citrate, pH 6.4 |
| Storage | -40°C or below |
| General tips | Dissolve it on ice and take care to prevent RNase contamination degradation. Avoid repeated freezing and thawing as much as possible. Do not vortex. For the first time, it is gently centrifuged and divided into several parts for stand-alone use. Use RNase-free reagents and consumables, using appropriate RNase-free technology. It can not be added to the serum-containing medium until it is mixed with the transfection reagent. |
| Shipping Condition | Ship with dry ice. |
- 1. Lijuan Shao, Yi Zhang, et al. "Synthetic efferocytic receptor microglia enhances anti-inflammatory clearance of amyloid-β for AD treatment in mice." Sci Adv. 2025 Jul 11;11(28):eads6613 PMID: 40632863
- 2. Harrison Douglas Lawson, Huy Hoang Nguyen, et al. "Synthetic Strategy for mRNA Encapsulation and Gene Delivery with Nanoscale Metal‐Organic Frameworks." ADVANCED FUNCTIONAL MATERIALS 19 May 2025
- 3. Jade Forrester, Callum G. Davidson, et al. "Low-Cost Microfluidic Mixers: Are They up to the Task?." Pharmaceutics. 2025 Apr 25;17(5):566 PMID: 40430858
- 4. Dao Thi Hong Le, Chuan Yang, et al. "Replacing PEG-Lipid with Amphiphilic Polycarbonates in mRNA-Loaded Lipid Nanoparticles: Impact of Polycarbonate Structure on Physicochemical and Transfection Properties." Biomacromolecules. 2025 Jun 9;26(6):3563-3575 PMID: 40347133
- 5. Nipuni Maniyamgama, Ki Hyun Bae, et al. "Muco‐Penetrating Lipid Nanoparticles Having a Liquid Core for Enhanced Intranasal mRNA Delivery." Adv Sci (Weinh). 2025 Mar;12(11):e2407383 PMID: 39888252
- 6. Li Zhang, Brandon Yi Loong Seow, et al. "Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines." J Control Release. 2025 Apr10:380:108-124 PMID: 39875076
- 7. Zixuan Zhen, Xinhao Lin, Mittal Darji. "Impact of cell line and reporter gene selection on in-vitro transfection evaluation of mRNA lipid nanoparticles." AAPS Open 11, 20 (2025)06 October.
- 8. Wenting Yang, Shangqian Li, Siqi Yu. "Combinatorial Discovery of RAFT Cationic Polymers for mRNA Delivery: Structure–Function Insights from High-Throughput Screening and Machine Learning." Biomacromolecules. 2025 Oct 6 PMID: 41053999
- 9. RYOHEI SHIMIZU, YOSHIYUKI HATTORI. "Effects of disaccharide and cationic lipid types on reverse transfection with lyophilized mRNA lipoplexes." EXPERIMENTAL AND THERAPEUTIC MEDICINE 30: 239, 2025
- 10. Yoshiyuki Hattori, Ryohei Shimizu et al. "Effective mRNA transfection of tumor cells using cationic triacyl lipid‑based mRNA lipoplexes." Biomed Rep. 2024 Dec 4;22(2):25 PMID: 39720303
- 11. Mohammed S Alqahtani, Rabbani Syed, et al. "Synthesis and bioactivity of a novel surfactin-based lipopeptide for mRNA delivery." Nanoscale Adv. 2024 Sep 4 PMID: 39247856
- 12. Min Tang, Yoshiyuki Hattori, et al. "Effect of vorinostat on protein expression in vitro and in vivo following mRNA lipoplex administration." Biomed Rep. 2024 May 27;21(1):105 PMID: 38868527
- 13. Franziska Haase, geb. Freitag aus Düsseldorf, Deutschland. "A novel class of mRNA lipid nanoparticles (LNPs) optimized by the chemical evolution approach." 2024
- 14. Franziska Haase, Jana Pöhmerer, et al. "Lipoamino bundle LNPs for efficient mRNA transfection of dendritic cells and macrophages show high spleen selectivity." Eur J Pharm Biopharm. 2024 Jan:194:95-109 PMID: 38065313
- 15. Mingzhu Gao, Maoping Tang, et al. "Modulating Plaque Inflammation via Targeted mRNA Nanoparticles for the Treatment of Atherosclerosis." ACS Nano. 2023 Sep 26;17(18):17721-17739 PMID: 37669404
- 16. Junyan Li, Yuanyuan Wu, et al. "Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines." Chem Eng J. 2023 Jan 15:456:140930 PMID: 36531858
Quality Control & Datasheet
- View current batch:
Related Biological Data

Related Biological Data

Related Biological Data

Related Biological Data

Related Biological Data






















